Anita J Gregory, PT | |
13726 E Monument Dr, Scottsdale, AZ 85262-7045 | |
(518) 369-6454 | |
Not Available |
Full Name | Anita J Gregory |
---|---|
Gender | Female |
Speciality | Physical Therapy |
Experience | 39 Years |
Location | 13726 E Monument Dr, Scottsdale, Arizona |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013080555 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | LPT-010233 (Arizona) | Primary |
225100000X | Physical Therapist | PT9635 (Washington) | Secondary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Forte - Phoenix Pllc | 7618240797 | 8 |
News Archive
A report in the Journal of the American Medical Association and a Mayo Clinic study examine medical school students' curriculum and stress levels.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today announced it recently received clearance from the European Medicines Agency to commence dosing patients in Europe in its global Phase II trial for CF102 in the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer.
Stomach and bowel cancer, two of the most common cancers worldwide, could be treated with a class of medicines that are currently used to treat a blood disorder, a Melbourne research team has discovered.
In addition to their physical injuries, women who are victims of domestic violence are also at a greater risk of mental health problems such as depression and psychotic symptoms. These are the findings of a study that was just published by a team of researchers at the Institute of Psychiatry, Psychology & Neuroscience at King's College London in England, the Institut universitaire en santé mentale de Montréal, and the University of Montreal.
› Verified 9 days ago
Provider Name | Forte - Phoenix Pllc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1255860342 PECOS PAC ID: 7618240797 Enrollment ID: O20170912002461 |
News Archive
A report in the Journal of the American Medical Association and a Mayo Clinic study examine medical school students' curriculum and stress levels.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today announced it recently received clearance from the European Medicines Agency to commence dosing patients in Europe in its global Phase II trial for CF102 in the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer.
Stomach and bowel cancer, two of the most common cancers worldwide, could be treated with a class of medicines that are currently used to treat a blood disorder, a Melbourne research team has discovered.
In addition to their physical injuries, women who are victims of domestic violence are also at a greater risk of mental health problems such as depression and psychotic symptoms. These are the findings of a study that was just published by a team of researchers at the Institute of Psychiatry, Psychology & Neuroscience at King's College London in England, the Institut universitaire en santé mentale de Montréal, and the University of Montreal.
› Verified 9 days ago
Provider Name | Arizona Luna Care Physical Therapy Llc |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1629698147 PECOS PAC ID: 8325469661 Enrollment ID: O20200522000830 |
News Archive
A report in the Journal of the American Medical Association and a Mayo Clinic study examine medical school students' curriculum and stress levels.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today announced it recently received clearance from the European Medicines Agency to commence dosing patients in Europe in its global Phase II trial for CF102 in the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer.
Stomach and bowel cancer, two of the most common cancers worldwide, could be treated with a class of medicines that are currently used to treat a blood disorder, a Melbourne research team has discovered.
In addition to their physical injuries, women who are victims of domestic violence are also at a greater risk of mental health problems such as depression and psychotic symptoms. These are the findings of a study that was just published by a team of researchers at the Institute of Psychiatry, Psychology & Neuroscience at King's College London in England, the Institut universitaire en santé mentale de Montréal, and the University of Montreal.
› Verified 9 days ago
Provider Name | Ancillary Care Strategies |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1821610353 PECOS PAC ID: 3678994589 Enrollment ID: O20200602000425 |
News Archive
A report in the Journal of the American Medical Association and a Mayo Clinic study examine medical school students' curriculum and stress levels.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today announced it recently received clearance from the European Medicines Agency to commence dosing patients in Europe in its global Phase II trial for CF102 in the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer.
Stomach and bowel cancer, two of the most common cancers worldwide, could be treated with a class of medicines that are currently used to treat a blood disorder, a Melbourne research team has discovered.
In addition to their physical injuries, women who are victims of domestic violence are also at a greater risk of mental health problems such as depression and psychotic symptoms. These are the findings of a study that was just published by a team of researchers at the Institute of Psychiatry, Psychology & Neuroscience at King's College London in England, the Institut universitaire en santé mentale de Montréal, and the University of Montreal.
› Verified 9 days ago
Provider Name | Orthopaedic And Neurological Rehab Inc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1225496540 PECOS PAC ID: 6507159126 Enrollment ID: O20200902001151 |
News Archive
A report in the Journal of the American Medical Association and a Mayo Clinic study examine medical school students' curriculum and stress levels.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today announced it recently received clearance from the European Medicines Agency to commence dosing patients in Europe in its global Phase II trial for CF102 in the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer.
Stomach and bowel cancer, two of the most common cancers worldwide, could be treated with a class of medicines that are currently used to treat a blood disorder, a Melbourne research team has discovered.
In addition to their physical injuries, women who are victims of domestic violence are also at a greater risk of mental health problems such as depression and psychotic symptoms. These are the findings of a study that was just published by a team of researchers at the Institute of Psychiatry, Psychology & Neuroscience at King's College London in England, the Institut universitaire en santé mentale de Montréal, and the University of Montreal.
› Verified 9 days ago
Provider Name | Restore Physical Therapy And Wellness |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1992479646 PECOS PAC ID: 7214326883 Enrollment ID: O20211119002137 |
News Archive
A report in the Journal of the American Medical Association and a Mayo Clinic study examine medical school students' curriculum and stress levels.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today announced it recently received clearance from the European Medicines Agency to commence dosing patients in Europe in its global Phase II trial for CF102 in the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer.
Stomach and bowel cancer, two of the most common cancers worldwide, could be treated with a class of medicines that are currently used to treat a blood disorder, a Melbourne research team has discovered.
In addition to their physical injuries, women who are victims of domestic violence are also at a greater risk of mental health problems such as depression and psychotic symptoms. These are the findings of a study that was just published by a team of researchers at the Institute of Psychiatry, Psychology & Neuroscience at King's College London in England, the Institut universitaire en santé mentale de Montréal, and the University of Montreal.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Anita J Gregory, PT 13726 E Monument Dr, Scottsdale, AZ 85262-7045 Ph: (518) 369-6454 | Anita J Gregory, PT 13726 E Monument Dr, Scottsdale, AZ 85262-7045 Ph: (518) 369-6454 |
News Archive
A report in the Journal of the American Medical Association and a Mayo Clinic study examine medical school students' curriculum and stress levels.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today announced it recently received clearance from the European Medicines Agency to commence dosing patients in Europe in its global Phase II trial for CF102 in the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer.
Stomach and bowel cancer, two of the most common cancers worldwide, could be treated with a class of medicines that are currently used to treat a blood disorder, a Melbourne research team has discovered.
In addition to their physical injuries, women who are victims of domestic violence are also at a greater risk of mental health problems such as depression and psychotic symptoms. These are the findings of a study that was just published by a team of researchers at the Institute of Psychiatry, Psychology & Neuroscience at King's College London in England, the Institut universitaire en santé mentale de Montréal, and the University of Montreal.
› Verified 9 days ago
Candice Anne Hill, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1475 N Granite Reef Rd, Scottsdale, AZ 85257 Phone: 480-990-1904 | |
Dr. Jeffrey Scott Abernethy, D.P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 7301 E 2nd St Ste 90, Scottsdale, AZ 85251 Phone: 480-882-6829 | |
Lifesource Therapeutics Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 7679 E Pinnacle Peak Rd, Suite100, Scottsdale, AZ 85255 Phone: 480-264-4599 Fax: 480-269-9201 | |
Jarad Coleman Brisbin, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 9219 E Hidden Spur Trl Ste 100, Scottsdale, AZ 85255 Phone: 602-648-5444 Fax: 602-772-3801 | |
Alexandria Cording, Physical Therapist Medicare: Medicare Enrolled Practice Location: 3337 N Miller Rd Ste 103, Scottsdale, AZ 85251 Phone: 480-687-2438 | |
Margy Kathleen Owen, PT, MS Physical Therapist Medicare: Medicare Enrolled Practice Location: 13400 E Shea Blvd, Scottsdale, AZ 85259 Phone: 480-301-8000 | |
Bonnie Kurth, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 15953 N Greenway Hayden Loop, Scottsdale, AZ 85260 Phone: 480-998-4848 Fax: 480-222-0268 |